Nymox Pharmaceutical
NYMX
#10184
Rank
NZ$30.3 M
Marketcap
Country
NZ$0.33
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Nymox Pharmaceutical (NYMX)

EPS in 2023 (TTM): NZ-$0.09947

According to Nymox Pharmaceutical's latest financial reports the company's current EPS (TTM) is NZ-$0.09962. In 2022 the company made an earnings per share (EPS) of NZ-$0.13 an increase over its 2021 EPS that were of NZ-$0.25.

EPS history for Nymox Pharmaceutical from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$0.09947-25.12%
2022NZ-$0.13-46.67%
2021NZ-$0.25-11.76%
2020NZ-$0.28-15%
2019NZ-$0.335.26%
2018NZ-$0.32-26.92%
2017NZ-$0.43-7.14%
2016NZ-$0.46-40.43%
2015NZ-$0.78291.67%
2014NZ-$0.20-7.69%
2013NZ-$0.22-43.48%
2012NZ-$0.38-25.81%
2011NZ-$0.5155%
2010NZ-$0.3325%
2009NZ-$0.270.08%
2008NZ-$0.27-11.12%
2007NZ-$0.30-0.16%
2006NZ-$0.3028.59%
2005NZ-$0.23-12.49%
2004NZ-$0.27-16.05%
2003NZ-$0.3219.07%
2002NZ-$0.2714.45%
2001NZ-$0.23-22.16%
2000NZ-$0.305.64%
1999NZ-$0.28-34.59%
1998NZ-$0.43-3.6%
1997NZ-$0.45

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$17.33-17,499.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.86-2,966.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.38-13,528.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$34.07-34,297.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$14.35-14,500.00%๐Ÿ‡บ๐Ÿ‡ธ USA